The index is a capitalization-weighted index considered representative of the health care market.
The index is a capitalization-weighted index considered representative of the health care market.
Mutual Fund to ETF Converter Tool
We’re sorry, there are no active ETFs associated with this index.
Sort By:
ETF Database staff has allocated each ETF in the ETF database, as well as each index, to a single ‘best-fit’ ETF Database Category. Other ETFs in the Health & Biotech Equities ETF Database Category are presented in the following table.
* Assets in thousands of U.S. Dollars.
Historical return data for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Fund flow information for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Expense information for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Dividend information for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Holdings data for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Tax Rate data for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Technical information for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Links to analysis of other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Links to a proprietary ETF Database rating for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
| Symbol | ETF Name | Asset Class | Total Assets* | YTD | Avg Volume | Previous Closing Price | 1-Day Change | Overall Rating | 1 Week | 1 Month | 1 Year | 3 Year | 5 Year | YTD FF | 1 Week FF | 4 Week FF | 1 Year FF | 3 Year FF | 5 Year FF | ETF Database | Inception | ER | Commission Free | Annual Dividend Rate | Dividend Date | Dividend | Annual Dividend Yield % | P/E Ratio | Beta | # of Holdings | % In Top 10 | Complete | ST Cap Gain Rate | LT Cap Gain Rate | Tax Form | Lower Bollinger | Upper Bollinger | Support 1 | Resistance 1 | RSI | Advanced | Fact Sheet | ETF Holdings | Chart | ETF Home Page | Head-To-Head | Liquidity Rating | Expenses Rating | Returns Rating | Volatility Rating | Dividend Rating | Concentration Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XLV | State Street Health Care Select Sector SPDR ETF | Equity | $41,683,800 | 4.8% | 10,233,632.0 | $160.84 | -0.82% | -1.8% | 4.5% | 20.0% | 9.4% | 6.3% | Health & Biotech Equities | 1998-12-16 | 0.08% | N/A | $2.53 | 2026-06-22 | $0.66 | 1.57% | 18.2 | 0.56 | 62 | 61.5% | View | 40% | 20% | 1099 | $146.86 | $166.66 | $159.83 | $162.25 | 60.71 | View | View | View | View | View | View | A | A | |||||||||||
| VHT | Vanguard Health Care ETF | Equity | $18,321,800 | 6.2% | 243,562.0 | $303.46 | -1.00% | -1.6% | 6.0% | 22.7% | 10.1% | 5.4% | Health & Biotech Equities | 2004-01-26 | 0.09% | Vanguard | $4.72 | 2026-06-24 | $0.99 | 1.56% | 27.3 | 0.60 | 427 | 51.7% | View | 40% | 20% | 1099 | $274.17 | $315.04 | $301.35 | $306.49 | 62.59 | View | View | View | View | View | View | A | A | |||||||||||
| XBI | State Street SPDR S&P Biotech ETF | Equity | $11,021,500 | 30.6% | 8,931,168.0 | $159.03 | -3.20% | -0.9% | 21.2% | 80.8% | 25.1% | 3.6% | Health & Biotech Equities | 2006-01-31 | 0.35% | N/A | $0.57 | 2026-06-22 | $0.14 | 0.36% | 19.1 | 0.82 | 152 | 12.8% | View | 40% | 20% | 1099 | $129.08 | $171.48 | $155.46 | $163.42 | 65.26 | View | View | View | View | View | View | A+ | A | |||||||||||
| IBB | iShares Biotechnology ETF | Equity | $9,605,990 | 13.9% | 1,539,246.0 | $192.06 | -2.68% | -1.9% | 13.4% | 44.1% | 15.9% | 3.6% | Health & Biotech Equities | 2001-02-05 | 0.44% | N/A | $0.41 | 2026-06-15 | $0.02 | 0.21% | 23.2 | 0.70 | 242 | 44.1% | View | 40% | 20% | 1099 | $164.34 | $203.65 | $189.30 | $196.14 | 63.72 | View | View | View | View | View | View | A | B | |||||||||||
| IXJ | iShares Global Healthcare ETF | Equity | $4,110,400 | 2.8% | 227,949.0 | $99.21 | -0.73% | -2.3% | 4.0% | 15.5% | 8.0% | 4.7% | Health & Biotech Equities | 2001-11-13 | 0.40% | N/A | $1.44 | 2026-06-15 | $0.85 | 1.46% | 24.8 | 0.57 | 112 | 47.4% | View | 40% | 20% | 1099 | $91.88 | $102.73 | $98.72 | $100.00 | 58.40 | View | View | View | View | View | View | A | B+ | |||||||||||
| FHLC | Fidelity MSCI Health Care Index ETF | Equity | $3,316,510 | 6.3% | 207,375.0 | $78.40 | -1.02% | -1.6% | 5.9% | 22.8% | 10.1% | 5.4% | Health & Biotech Equities | 2013-10-21 | 0.08% | Fidelity | $1.02 | 2026-06-18 | $0.26 | 1.30% | 26.8 | 0.60 | 334 | 52.1% | View | 40% | 20% | 1099 | $70.86 | $81.38 | $77.91 | $79.10 | 62.66 | View | View | View | View | View | View | A | A+ | |||||||||||
| IYH | iShares U.S. Healthcare ETF | Equity | $3,240,540 | 4.9% | 730,122.0 | $67.89 | -1.06% | -1.9% | 4.8% | 20.1% | 8.9% | 5.2% | Health & Biotech Equities | 2000-06-12 | 0.38% | N/A | $0.80 | 2026-06-15 | $0.16 | 1.18% | 26.8 | 0.58 | 102 | 59.1% | View | 40% | 20% | 1099 | $61.65 | $70.56 | $67.47 | $68.51 | 60.71 | View | View | View | View | View | View | B+ | B+ | |||||||||||
| IHI | iShares U.S. Medical Devices ETF | Equity | $3,136,850 | -17.2% | 2,739,876.0 | $51.34 | 0.12% | -1.0% | 0.9% | -16.9% | -1.8% | -3.1% | Health & Biotech Equities | 2006-05-01 | 0.38% | N/A | $0.24 | 2026-06-15 | $0.08 | 0.47% | 29.4 | 0.82 | 48 | 74.7% | View | 40% | 20% | 1099 | $48.11 | $52.42 | $51.04 | $51.62 | 53.65 | View | View | View | View | View | View | A | A- | |||||||||||
| FBT | First Trust NYSE Arca Biotechnology Index Fund | Equity | $2,853,890 | 20.9% | 61,684.0 | $249.59 | -2.51% | -2.3% | 10.4% | 47.8% | 18.9% | 8.0% | Health & Biotech Equities | 2006-06-19 | 0.55% | N/A | $0.00 | 2024-12-13 | $1.17 | 0.00% | 27.3 | 0.65 | 31 | 43.2% | View | 40% | 20% | 1099 | $217.78 | $264.05 | $246.67 | $254.28 | 66.18 | View | View | View | View | View | View | B+ | B- | |||||||||||
| ARKG | ARK Genomic Revolution ETF | Equity | $1,680,680 | 42.6% | 3,232,351.0 | $41.32 | -3.91% | -3.7% | 23.1% | 58.2% | 7.6% | -14.3% | Health & Biotech Equities | 2014-10-31 | 0.75% | N/A | $0.00 | 2021-12-29 | $0.38 | 0.00% | N/A | 1.69 | 33 | 60.2% | View | 40% | 20% | 1099 | $32.23 | $46.11 | $40.19 | $42.76 | 63.21 | View | View | View | View | View | View | A | C+ | |||||||||||
| Click Here to Join to ETF Database Pro for 14 Days Free, Export This Data & So Much More | ||||||||||||||||||||||||||||||||||||||||||||||||||||
A long-running debate in asset allocation circles is how much of a portfolio an investor should...
In a digital age where information moves in milliseconds and millions of participants can transact...